Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

By Germino F. Wilford  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan in the Treatment of Mild-to-Moderate Essential Hypertension in Chinese Patients

By Liau Chiau-Suong  

Clinical Drug Investigation, Vol. 25, Iss. 7, 2005-01 ,pp. : 473-479

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension

By Brunner H.R.  

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 419-430

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Olmesartan Medoxomil in Patients with Mild to Moderate Essential Hypertension: The OLMEBEST Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 27, Iss. 8, 2007-01 ,pp. : 545-558

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension: An Open-Label, Long-Term Study

By Volpe Massimo   Miele Cristina  

Clinical Drug Investigation, Vol. 29, Iss. 6, 2009-05 ,pp. : 381-391

Adis International

Access to resources Recommend Favorite